A Study of the Novel Drug Dimebon in Patients With Huntington's Disease (DIMOND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00497159
Recruitment Status : Completed
First Posted : July 6, 2007
Last Update Posted : June 8, 2015
Huntington Study Group
Information provided by (Responsible Party):
Medivation, Inc.